免疫球蛋白用于严重肌痛性肌痛症
Apostolos Manolopoulos1, Muayad Alzuabi2, Amjad Elmashala3
1Laboratory of Clinical Investigation, Intramural Research Program, National Institute on Aging, NIH, Baltimore, MD, USA.
The Cochrane database of systematic reviews
|October 15, 2025
概括
静脉注射免疫球蛋白 (IVIg) 与安慰剂相比,对肌痛严重症 (MG) 症状的改善具有有限的益处,头痛的发病率更高. 有证据表明IVIg可能比血交换 (PLEX) 效率低,并且可以延长住院时间.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 临床试验 临床试验
背景情况:
- 免疫球蛋白疗法用于神经免疫性疾病,如肌痛性硬化症 (MG).
- 免疫球蛋白在MG中有效性的证据是不确定的.
- 通用性MG需要有效的治疗选择.
研究的目的:
- 评估免疫球蛋白在通用MG中的益处和危害.
- 比较静脉注射免疫球蛋白 (IVIg) 与皮下免疫球蛋白 (SCIg).
- 比较免疫球蛋白 (任何途径) 与安慰剂,血交换 (PLEX),皮质类固醇或其他治疗方法.
主要方法:
- 包括并行和交叉随机对照试验 (RCT).
- 搜索了多个数据库,包括Cochrane,MEDLINE,Embase和临床试验.gov.gov.
- 使用RoB 2工具评估偏差风险和使用GRADE的证据确定性.
主要成果:
- 低确定性证据表明IVIg可能比安慰剂提供轻微的中期症状改善,而不是临床显著.
- 中等确定性证据表明,IVIg与安慰剂相比,增加了头痛发生率.
- 非常低至低确定性证据表明,IVIg在短期症状改善方面可能不如PLEX有效,并可能延长住院时间.
结论:
- 目前在MG中IVIg的证据确定性低至非常低.
- 需要高质量的试验,包括对SCIg和新疗法的比较.
- IVIg对MG的益处有限,并且与头痛增加和潜在的更长的住院时间有关.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Disorders of the Skeletal Muscle
1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Myocarditis III: Medical Management
174
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
174
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
488
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
488
Chemical Synapses
11.3K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
11.3K


